Fig. 2From: Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patientsANN for predicting the risk of BRCA1/2 germline mutation in Chinese bilateral breast cancer patients. (A) Three layers of the ANN model. The accuracy of ANN in BRCA (B), BRCA1(C) and BRCA2(D) germline mutation prediction are assessed by ROC curveBack to article page